Semaglutide 1 mg demonstrated statistically significant and superior improvement in maximum walking distance by 13% over placebo in adults with type 2 diabetes and symptomatic PAD 1 Based on STRIDE ...
Bagsværd, Denmark, 29 March 2025 – Novo Nordisk today presented the full results from STRIDE, a phase 3b peripheral artery disease (PAD) outcomes trial investigating the effects of once-weekly ...
April 14 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being distributed outside its authorized ...
Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they’re set to cost the U.S. health care system and the federal government still more this year and beyond, two new reports ...
A shortage of diabetes drug Ozempic that is used off-label for weight loss is expected in Canada, manufacturer Novo Nordisk and Health Canada said on Friday. “We are experiencing a temporary supply ...
Sen. Marsha Blackburn and Tennessee Attorney General Jonathan Skrmetti are urging the Federal Trade Commission to investigate potentially dangerous, misleadingly advertised GLP-1 drugs. Counterfeit ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback